Jaundice laboratory findings: Difference between revisions
Jump to navigation
Jump to search
Line 15: | Line 15: | ||
*** Conjugated bilirubin is <1 mg/dL (17 micromol/L) if the total bilirubin is <5 mg/dL, or less than 20 percent of the total bilirubin if the total bilirubin is >5 mg/dL (85 micromol/L).<ref name="pmid21250253">{{cite journal |vauthors=Walker HK, Hall WD, Hurst JW, Stillman AE |title= |journal= |volume= |issue= |pages= |year= |pmid=21250253 |doi= |url=}}</ref> | *** Conjugated bilirubin is <1 mg/dL (17 micromol/L) if the total bilirubin is <5 mg/dL, or less than 20 percent of the total bilirubin if the total bilirubin is >5 mg/dL (85 micromol/L).<ref name="pmid21250253">{{cite journal |vauthors=Walker HK, Hall WD, Hurst JW, Stillman AE |title= |journal= |volume= |issue= |pages= |year= |pmid=21250253 |doi= |url=}}</ref> | ||
* FBC detect haemolysis. | * FBC detect haemolysis. | ||
* ESR may be rise in PBC. | |||
* Lactate dehydrogenase elevated in haemolysis. | |||
* LFTs: | |||
** Alkaline phosphatase: considerably increased with either extrahepatic or intrahepatic biliary disease. The most common diseases associated with raised alkaline phosphatase include: | |||
*** Gallstones causing bile duct obstruction. | |||
*** Pancreatic cancer. | |||
*** Pregnancy. | |||
*** Drugs. | |||
*** More rarely, PBC. | |||
** Serum transaminases are usually very high in hepatocellular disease (like viral hepatitis) but more modestly elevated in chronic hepatocellular damage and obstruction: | |||
*** Aspartate aminotransferase (AST) is raised more than alanine aminotransferase (ALT) in cirrhosis, intrahepatic neoplasia, haemolytic jaundice and alcoholic hepatitis. | |||
*** ALT is raised more than AST in acute hepatitis and in extrahepatic obstruction. | |||
*** ALT levels of less than 100 IU/L with jaundice suggest obstructive jaundice. | |||
*** ALT over 400 IU/L suggests diffuse acute hepatocellular damage (for example, in viral hepatitis). | |||
*** ALT between 150-400 IU/L suggests chronic active hepatitis or viral or drug-induced hepatitis. | |||
*** Very high levels of ALT (over 1,000 IU/L) suggest acute parenchymal disease. | |||
** Gamma-glutamyltransferase (GGT): | |||
*** GGT is sensitive but not specific for excess alcohol intake. | |||
*** A raised MCV with raised GGT is suggestive of alcohol abuse and, if accompanied by raised ALT, suggests liver cell damage. | |||
*** Biliary obstruction and hepatic malignancies cause very high GGT levels (x 10 normal). | |||
*** Raised GGT with raised alkaline phosphatase (over x 3 normal) suggests cholestasis. | |||
* Hepatitis serology should be done in all patients with cholestasis, as differentiating hepatitis from extrahepatic obstructive causes may be very difficult. | |||
* Prothrombin time may be prolonged because of vitamin K malabsorption. Injection of vitamin K will correct deficiency in cholestasis but not in parenchymal liver disease. | |||
* Serum antinuclear antibodies (ANAs), anti-smooth muscle antibody (ASMA): the hallmark of PBC is antimitochondrial antibodies (90-95% of patients with PBC are positive); ANA is positive in 20-50% of patients with PBC. | |||
* Serum immunoglobulins and serum electrophoresis in acute hepatitis when autoimmune hepatitis is suspected. IgG is raised in acute hepatitis, IgM is raised in autoimmune disease, PBC or chronic infection. | |||
* Alpha-1-antitrypsin levels: | |||
** deficiency causes cirrhosis | |||
==References== | ==References== |
Revision as of 19:45, 5 February 2018
Jaundice Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Jaundice laboratory findings On the Web |
American Roentgen Ray Society Images of Jaundice laboratory findings |
Risk calculators and risk factors for Jaundice laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Laboratory Findings
- Laboratory findings consistent with the diagnosis of jaundice include:
- An elevated concentration of serum total bilirubin. the upper limit of normal is >1 mg/dL or >1.3 mg/d in some laboratories. Jaundice usually becomes clinically apparent when the serum total bilirubin concentration is greater than 2 to 3 mg/dL , but threshold for clinically apparent jaundice may vary among patients.[1]
- Hyperbilirubinemia can be further categorized as conjugated or unconjugated:
- Conjugated hyperbilirubinemia:
- Serum conjugated bilirubin concentration >0.4 mg/dL (6.8 micromol/L).
- Direct bilirubin >1 mg/dL (17 micromol/L) if the total bilirubin is <5 mg/dL (85 micromol/L), or more than 20 percent of the total bilirubin if the total bilirubin is >5 mg/dL(85 micromol/L).[1]
- Unconjugated hyperbilirubinemia:
- Conjugated bilirubin is <1 mg/dL (17 micromol/L) if the total bilirubin is <5 mg/dL, or less than 20 percent of the total bilirubin if the total bilirubin is >5 mg/dL (85 micromol/L).[1]
- Conjugated hyperbilirubinemia:
- FBC detect haemolysis.
- ESR may be rise in PBC.
- Lactate dehydrogenase elevated in haemolysis.
- LFTs:
- Alkaline phosphatase: considerably increased with either extrahepatic or intrahepatic biliary disease. The most common diseases associated with raised alkaline phosphatase include:
- Gallstones causing bile duct obstruction.
- Pancreatic cancer.
- Pregnancy.
- Drugs.
- More rarely, PBC.
- Serum transaminases are usually very high in hepatocellular disease (like viral hepatitis) but more modestly elevated in chronic hepatocellular damage and obstruction:
- Aspartate aminotransferase (AST) is raised more than alanine aminotransferase (ALT) in cirrhosis, intrahepatic neoplasia, haemolytic jaundice and alcoholic hepatitis.
- ALT is raised more than AST in acute hepatitis and in extrahepatic obstruction.
- ALT levels of less than 100 IU/L with jaundice suggest obstructive jaundice.
- ALT over 400 IU/L suggests diffuse acute hepatocellular damage (for example, in viral hepatitis).
- ALT between 150-400 IU/L suggests chronic active hepatitis or viral or drug-induced hepatitis.
- Very high levels of ALT (over 1,000 IU/L) suggest acute parenchymal disease.
- Gamma-glutamyltransferase (GGT):
- GGT is sensitive but not specific for excess alcohol intake.
- A raised MCV with raised GGT is suggestive of alcohol abuse and, if accompanied by raised ALT, suggests liver cell damage.
- Biliary obstruction and hepatic malignancies cause very high GGT levels (x 10 normal).
- Raised GGT with raised alkaline phosphatase (over x 3 normal) suggests cholestasis.
- Alkaline phosphatase: considerably increased with either extrahepatic or intrahepatic biliary disease. The most common diseases associated with raised alkaline phosphatase include:
- Hepatitis serology should be done in all patients with cholestasis, as differentiating hepatitis from extrahepatic obstructive causes may be very difficult.
- Prothrombin time may be prolonged because of vitamin K malabsorption. Injection of vitamin K will correct deficiency in cholestasis but not in parenchymal liver disease.
- Serum antinuclear antibodies (ANAs), anti-smooth muscle antibody (ASMA): the hallmark of PBC is antimitochondrial antibodies (90-95% of patients with PBC are positive); ANA is positive in 20-50% of patients with PBC.
- Serum immunoglobulins and serum electrophoresis in acute hepatitis when autoimmune hepatitis is suspected. IgG is raised in acute hepatitis, IgM is raised in autoimmune disease, PBC or chronic infection.
- Alpha-1-antitrypsin levels:
- deficiency causes cirrhosis